Codis, a global contract development and manufacturing organization (CDMO) specializing in spray drying, amorphous solid dispersions (ASDs), and advanced particle engineering solutions, announced an agreement with Catalent Pharma Solutions ("Catalent") to acquire Catalent's facility in Nottingham, UK. The acquisition,…
Ipsen and Memo Therapeutics AG announced they have entered into a definitive share purchase agreement under which Ipsen has agreed to acquire all issued and outstanding shares of Memo Therapeutics AG. The anticipated acquisition is focused on potravitug, which is a Phase II clinical-stage antibody against the BK polyo…
Radnostix, Inc., a leader in radioisotope production and nuclear medicine solutions, announced the successful closing of its acquisition of key assets from Lucerno Dynamics, LLC, including the LARA System technology platform, ELLEXA Explorer software and associated intellectual property. The product line was original…
AGC Biologics enters a strategic partnership with Pyramid Pharma Services. The collaboration combines AGC Biologics’ expertise in drug substance development and manufacturing with Pyramid’s sterile fill-finish capabilities, creating a differentiated U.S.-based offering and providing developers with a fully integrated …
Nona Biosciences, a global biotechnology company advancing biologics discovery and development through innovative technology platforms, announced a strategic collaboration with Lonza to develop best-in-class single-domain antibody–based blood-brain barrier (BBB)-crossing technology for central nervous system (CNS) dis…
Insilico Medicine, a leader in clinical-stage generative AI for drug discovery, announced a strategic collaboration agreement with Takeda to use its proprietary end-to-end platform, Pharma.AI, to advance drug candidates across the company's therapeutic areas. The collaboration is designed to identify clinically diffe…
Eurobio Scientific, a leading French group in in-vitro diagnostics for transplantation, oncology and infectious diseases, announces that it has closed the acquisition of CareDx AB in Sweden and its fully owned subsidiaries in the United States and Australia that constitutes the Lab Products division of CareDx, Inc., a…
Cadila Pharmaceuticals, one of India’s leading integrated pharmaceutical companies, and Wellesta Holdings Pte.Ltd., Singapore, have signed a Memorandum of Understanding (MoU) to establish a strategic Joint Venture aimed at expanding access to high-quality healthcare solutions across South-East Asia and selected intern…
Lonza, the world’s leading contract development and manufacturing organization (CDMO), announced an expanded strategic collaboration with a leading US-based biopharmaceutical company. The expansion adds two biologics programs to be produced commercially, with the option for two more, and further strengthens an estab…
Merck, a leading science and technology company, and Bio-Techne Corporation, a Minneapolis-based global provider of life science tools, analytical technologies, and consumables, entered into a definitive agreement pursuant to which Merck will, subject to customary closing conditions, acquire Bio-Techne for US$73 per s…
Page 6 of 39